stockrowargenex SE
ARGX Healthcare Biotechnology
argenex SE’s revenue for fiscal 2025 (year ended December 2025) was $4.2 billion, up 88.6% from fiscal 2024.
- Revenue
- +52.1%
- EPS
- +43.9%
- Free cash flow
- +537.5%
Quarter to September 2026, against a year earlier
Follow ARGX
Alert me
argenex SE (ARGX) Operating margin
argenex SE's operating margin over the twelve months to 30 September 2026 was 29.3%, up 4.5 percentage points from fiscal 2025 (24.8%). Over the past ten years it has ranged from −735.8% (fiscal 2020) to 24.8% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 24.8% | 25.77 |
| FY2024 | −0.96% | 32.55 |
| FY2023 | −33.5% | 128.27 |
| FY2022 | −161.8% | (97.13) |
| FY2021 | −64.7% | 671.15 |
| FY2020 | −735.8% | (519.59) |
| FY2019 | −216.2% | 63.80 |
| FY2018 | −280.0% | (224.43) |
| FY2017 | −55.6% | 69.28 |
| FY2016 | −124.9% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 27.7% | (4.34) |
| Jun 2026 | 32.0% | 2.03 |
| Mar 2026 | 30.0% | 2.29 |
| Dec 2025 | 27.7% | (2.43) |
| 25 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 57.1% |
| ARGX argenex SE | 29.3% |
| REGN Regeneron Pharmaceuticals, Inc. compare | 28.8% |
| GMAB Genmab A/S Sponsored ADR compare | 26.0% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 17.8% |
| INCY Incyte Corporation compare | 10.4% |
| MRNA Moderna, Inc. compare | −149.0% |
| RVMD Revolution Medicines, Inc. compare | −805.8% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ARGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement